Top

Published in:

01-08-2023 | Urticaria | Clinical study

Low risk of urticaria exacerbation following COVID-19 vaccination

Published in: Reactions Weekly | Issue 1/2023

Excerpt

The risk of urticaria exacerbation in patients with chronic urticaria (CU) receiving COVID-19 vaccination is low. …

Kocaturk E, et al. Urticaria Exacerbations and Adverse Reactions in Patients with Chronic Urticaria Receiving COVID-19 Vaccination: Results of the UCARE COVAC-CU Study. Journal of Allergy and Clinical Immunology : 11 Aug 2023. Available from: URL: http://doi.org/10.1016/j.jaci.2023.07.019

Title: Low risk of urticaria exacerbation following COVID-19 vaccination
Publication date: 01-08-2023
Publisher: Springer International Publishing
Keywords: Urticaria
COVID-19 Vaccination
Omalizumab
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-45134-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Low risk of urticaria exacerbation following COVID-19 vaccination

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Infliximab/mesalazine/vedolizumab

Multiple drugs

Methylprednisolone

Darbepoetin-alfa/ferric-citrate/roxadustat

Ethinylestradiol/gestodene

Clomipramine/fluvoxamine